Parents speak out over Indian trial recruitment; NICE wants study data made public;

> As the controversy over clinical trial regulations in India continues to heat up, parents in Bangalore are up in arms after their elementary-aged kids were recruited for a dental study. Article

> According to a Tufts study, 48% of clinical trial sites miss their enrollment targets and prolong study timelines. Story

> The U.K.'s NICE wants all of the country's clinical trial data to be made public. Item

> ADC Biotechnology has raised about $1 million and plans to use it to market its antibody drug conjugate development services. News

> PaxVax, a contract vaccine manufacturer, has upgraded its San Diego facility to better produce its single-dose oral cholera vaccine. More

> U.K. CMO Aesica is partnering with universities is Durham and Leeds to develop ways to optimize its API production, cutting costs and increasing output. Item

 

Suggested Articles

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.